Cargando…

Cutaneous vasculitis following COVID-19 vaccination

Detalles Bibliográficos
Autores principales:	Cavalli, Giulio, Colafrancesco, Serena, De Luca, Giacomo, Rizzo, Nathalie, Priori, Roberta, Conti, Fabrizio, Dagna, Lorenzo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8483649/ https://www.ncbi.nlm.nih.gov/pubmed/34611627 http://dx.doi.org/10.1016/S2665-9913(21)00309-X

Ejemplares similares

The right place for IL-1 inhibition in COVID-19
por: Cavalli, Giulio, et al.
Publicado: (2021)

The course of action for effective anti-cytokine treatment in COVID-19
por: Cavalli, Giulio, et al.
Publicado: (2021)

COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome?
por: Colafrancesco, Serena, et al.
Publicado: (2020)

Targeting the Immune System for Pulmonary Inflammation and Cardiovascular Complications in COVID-19 Patients
por: Colafrancesco, Serena, et al.
Publicado: (2020)

Cutaneous vasculitis following COVID-19 vaccination
Publicado: (2021)

Response to Berry et al’s “Cutaneous small-vessel vasculitis following single-dose Janssen Ad26.COV2.S vaccination”
por: Matthews, Natalie H., et al.
Publicado: (2022)

The conundrum of interleukin-6 blockade in COVID-19
por: Campochiaro, Corrado, et al.
Publicado: (2020)

Adult-onset Still's disease following COVID-19 vaccination
por: Leone, Flavia, et al.
Publicado: (2021)

Granulocyte-macrophage colony stimulating factor in COVID-19: friend or foe?
por: Mehta, Puja, et al.
Publicado: (2021)

Relapses of idiopathic inflammatory myopathies after vaccination against COVID-19: a real-life multicenter Italian study
por: Conticini, Edoardo, et al.
Publicado: (2022)

COVID-19 in systemic vasculitis and polymyalgia rheumatica: who is at risk of poor outcomes?
por: Monti, Sara
Publicado: (2021)

Cutaneous vasculitis due to COVID-19 vaccination()
por: Gázquez Aguilera, Elena María, et al.
Publicado: (2022)

Mavrilimumab for severe COVID-19 – Authors' reply
por: De Luca, Giacomo, et al.
Publicado: (2020)

IL-1 and IL-6 inhibition affects the neutralising activity of anti-SARS-CoV-2 antibodies in patients with COVID-19
por: Della-Torre, Emanuel, et al.
Publicado: (2021)

Leukocytoclastic vasculitis (cutaneous small-vessel vasculitis) after COVID-19 vaccination
por: Fiorillo, G., et al.
Publicado: (2022)

Effect of anakinra in COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness
por: Cavalli, Giulio, et al.
Publicado: (2020)

Radiation Recall Phenomenon Following COVID-19 Vaccination
por: Stewart, Rachel, et al.
Publicado: (2021)

Comment to “Deep vein thrombosis induced by vasculitis in the Behçet's syndrome”
por: Guo, Ya-Nan, et al.
Publicado: (2019)

The last word on COVID-19 vaccines and breastfeeding?
por: Balduit, Andrea, et al.
Publicado: (2023)

Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts
por: Colafrancesco, Serena, et al.
Publicado: (2019)

Correction to: Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts
por: Colafrancesco, Serena, et al.
Publicado: (2020)

Carditis following COVID-19 vaccination: balancing the risks and benefits
por: Ling, Ryan Ruiyang, et al.
Publicado: (2023)

Implications of COVID-19 vaccine effectiveness waning for public health
por: Odone, Anna, et al.
Publicado: (2022)

Indolent cutaneous lymphoma with gamma/delta expression after COVID-19 vaccination
por: Hobayan, Catherine Grace, et al.
Publicado: (2022)

Low frequency of disease flare in patients with rheumatic musculoskeletal diseases who received SARS-CoV-2 mRNA vaccine
por: Spinelli, Francesca Romana, et al.
Publicado: (2022)

Sinovac COVID-19 vaccine–induced cutaneous leukocytoclastic vasculitis
por: Bencharattanaphakhi, Rungrot, et al.
Publicado: (2021)

COVID-19 in Italian Sjögren's syndrome patients: a monocentric study
por: Giardina, F., et al.
Publicado: (2020)

Myocarditis: An Interleukin-1-Mediated Disease?
por: De Luca, Giacomo, et al.
Publicado: (2018)

Cutaneous vasculitis: Lessons from COVID-19 and COVID-19 vaccination
por: Corrà, Alberto, et al.
Publicado: (2022)

How the andrological sector suffered from the dramatic Covid 19 outbreak in Italy: supportive initiatives of the Italian Association of Andrology (SIA)
por: Rizzo, Michele, et al.
Publicado: (2020)

Attention all anti-vaccinators: The cutaneous adverse events from the mRNA COVID-19 vaccines are not an excuse to avoid them!
por: Gronbeck, Christian, et al.
Publicado: (2021)

Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster
por: Hung, Ivan F N, et al.
Publicado: (2021)

Refractory rheumatoid vasculitis—a therapeutic dilemma
por: Watts, Richard A, et al.
Publicado: (2016)

Large-vessel vasculitis following the Pfizer-BioNTech COVID-19 vaccine
por: Gilio, Michele, et al.
Publicado: (2022)

COVID-19 vaccine effectiveness and evolving variants: understanding the immunological footprint
por: Zaeck, Luca M, et al.
Publicado: (2023)

Cutaneous skin manifestation following messenger RNA Moderna SARS-CoV-2 vaccine with dermal hypersensitivity reaction histopathology
por: Chopra, Shara, et al.
Publicado: (2021)

Anakinra for patients with COVID-19 – Authors' reply
por: Cavalli, Giulio, et al.
Publicado: (2020)

Repurposing of Biologic and Targeted Synthetic Anti-Rheumatic Drugs in COVID-19 and Hyper-Inflammation: A Comprehensive Review of Available and Emerging Evidence at the Peak of the Pandemic
por: Cavalli, Giulio, et al.
Publicado: (2020)

Moving forward with an imperfect vaccine
por: Pezzoli, Lorenzo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v8okuvsgqkek2m81tubluom76s